- Home
- GDTC vs AIXC Comparison
GDTC vs AIXC Comparison
Compare GDTC & AIXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GDTC | AIXC |
|---|---|---|
| Founded | 2018 | 1996 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.5M | 13.7M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | GDTC | AIXC |
|---|---|---|
| Price | $0.94 | $2.42 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 38.4K | ★ 66.3K |
| Earning Date | 04-24-2026 | 02-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $573,193.00 | N/A |
| Revenue This Year | $5.37 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 63.03 | N/A |
| 52 Week Low | $0.89 | $1.61 |
| 52 Week High | $3.68 | $8.81 |
Technical Indicators
Market Signals| Indicator | GDTC | AIXC |
|---|---|---|
| Relative Strength Index (RSI) | 20.48 | N/A |
| Support Level | $0.89 | N/A |
| Resistance Level | $1.39 | N/A |
| Average True Range (ATR) | 0.13 | 0.00 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 7.13 | 0.00 |
Price Performance
Historical ComparisonAbout GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About AIXC AIxCrypto Holdings Inc.
AIxCrypto Holdings Inc is a Web3-driven decentralized artificial intelligence technology platform.